Aptamer Group (LON:APTA) Trading Down 7.2% – Should You Sell?

Aptamer Group plc (LON:APTAGet Free Report)’s stock price was down 7.2% on Wednesday . The company traded as low as GBX 0.33 and last traded at GBX 0.35. Approximately 11,767,139 shares were traded during trading, an increase of 123% from the average session volume of 5,272,978 shares. The stock had previously closed at GBX 0.38.

Aptamer Group Stock Up 0.9%

The company has a market capitalization of £11.33 million, a PE ratio of -2.98 and a beta of 0.90. The company’s 50 day moving average is GBX 0.46 and its two-hundred day moving average is GBX 0.60.

About Aptamer Group

(Get Free Report)

Aptamer Group is a leading provider of aptamer selection services and developer of aptamer-based reagents for use in research, bioprocessing, diagnostic, and therapeutic applications. Headquartered in York, UK, the Company partners globally to deliver aptamer-based solutions that drive discovery and development across the life sciences.

Aptamer Group has developed the proprietary Optimer® platform technology that drives three distinct businesses: Aptamer Solutions, Aptamer Diagnostics and Aptamer Therapeutics.

Further Reading

Receive News & Ratings for Aptamer Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aptamer Group and related companies with MarketBeat.com's FREE daily email newsletter.